AAUM (Average Assets Under Management) of ₹2,978.34 Cr for Apr-Jun 2026 is the combined figure across Direct and Regular plans — sourced from AMFI India's quarterly disclosure. Equity Holdings above shows only the stock portion from the latest portfolio filing.
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 75.5% | 74.9% | ▼ -0.5% |
| Healthcare Services | 22.8% | 23.8% | ▲ +1.0% |
| Chemicals & Petrochemicals | 1.1% | 1.1% | ● 0.0% |
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 74.9% | 74.8% | ▼ -0.2% |
| Healthcare Services | 23.8% | 22.9% | ▼ -0.8% |
| Chemicals & Petrochemicals | 1.1% | 1.1% | ● 0.0% |
Comparing Jun 2026 → Jul 2026
| # | Stock | Sector | Last Weight (Jun 2026) |
|---|---|---|---|
| 1 | JB Chemicals & Pharmaceuticals Limited ₹211.07 Cr |
Pharmaceuticals & Biotechnology | 6.49% |
| # | Stock | Sector | Jun 2026 | Jul 2026 | Change |
|---|---|---|---|---|---|
| 1 | Torrent Pharmaceuticals Limited ₹257.27 Cr |
Pharmaceuticals & Biotechnology | 0.46% | 7.47% | +7.01% |
| 2 | Biocon Limited ₹71.51 Cr |
Pharmaceuticals & Biotechnology | 0.52% | 2.08% | +1.56% |
| 3 | Divi's Laboratories Limited ₹299.83 Cr |
Pharmaceuticals & Biotechnology | 7.53% | 8.71% | +1.18% |
| 4 | Laurus Labs Limited ₹176.67 Cr |
Pharmaceuticals & Biotechnology | 4.61% | 5.13% | +0.52% |
| 5 | Dr. Lal Path Labs Limited ₹96.88 Cr |
Healthcare Services | 2.57% | 2.81% | +0.24% |
| 6 | Sun Pharmaceutical Industries Limited ₹380.60 Cr |
Pharmaceuticals & Biotechnology | 10.95% | 11.06% | +0.11% |
| 7 | Alkem Laboratories Limited ₹122.45 Cr |
Pharmaceuticals & Biotechnology | 3.54% | 3.56% | +0.02% |
| # | Stock | Sector | Jun 2026 | Jul 2026 | Change |
|---|---|---|---|---|---|
| 1 | Dr. Reddy's Laboratories Limited ₹119.18 Cr |
Pharmaceuticals & Biotechnology | 4.33% | 3.46% | -0.87% |
| 2 | Lupin Limited ₹112.58 Cr |
Pharmaceuticals & Biotechnology | 4.13% | 3.27% | -0.86% |
| 3 | Glenmark Pharmaceuticals Limited ₹190.26 Cr |
Pharmaceuticals & Biotechnology | 6.09% | 5.53% | -0.56% |
| 4 | Aurobindo Pharma Limited ₹131.66 Cr |
Pharmaceuticals & Biotechnology | 4.33% | 3.82% | -0.51% |
| 5 | Gland Pharma Limited ₹72.63 Cr |
Pharmaceuticals & Biotechnology | 2.49% | 2.11% | -0.38% |
| 6 | Krishna Institute Of Medical Sciences Limited ₹119.63 Cr |
Healthcare Services | 3.85% | 3.48% | -0.37% |
| 7 | Eris Lifesciences Limited ₹97.17 Cr |
Pharmaceuticals & Biotechnology | 3.16% | 2.82% | -0.34% |
| 8 | Fortis Healthcare Limited ₹122.20 Cr |
Healthcare Services | 3.80% | 3.55% | -0.25% |
| 9 | Max Healthcare Institute Limited ₹96.83 Cr |
Healthcare Services | 3.06% | 2.81% | -0.25% |
| 10 | Cipla Limited ₹104.39 Cr |
Pharmaceuticals & Biotechnology | 3.19% | 3.03% | -0.16% |
27 stocks — Jul 2026
| # | Stock | Sector | Cap | Weight & Value |
|---|---|---|---|---|
| 1 |
₹380.60 Cr |
Pharmaceuticals & Biotechnology |
11.06%
|
|
| 2 |
₹299.83 Cr |
Pharmaceuticals & Biotechnology |
8.71%
|
|
| 3 |
₹257.27 Cr |
Pharmaceuticals & Biotechnology |
7.47%
|
|
| 4 |
₹204.48 Cr |
Healthcare Services |
5.94%
|
|
| 5 |
₹190.26 Cr |
Pharmaceuticals & Biotechnology |
5.53%
|
|
| 6 |
₹176.67 Cr |
Pharmaceuticals & Biotechnology |
5.13%
|
|
| 7 |
₹131.66 Cr |
Pharmaceuticals & Biotechnology |
3.82%
|
|
| 8 |
₹122.45 Cr |
Pharmaceuticals & Biotechnology |
3.56%
|
|
| 9 |
₹122.20 Cr |
Healthcare Services |
3.55%
|
|
| 10 |
₹119.63 Cr |
Healthcare Services |
3.48%
|
Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.
Found a discrepancy or have feedback? Contact Us — we read every message personally.